ZoomRx Launches 'Sagan' – An AI-Powered Platform Revolutionizing Pharma Market Research

June 13, 2025 02:15 AM AEST | By EIN Presswire

Google News:

ZoomRx Launches 'Sagan' – An AI-Powered Platform Revolutionizing Pharma Market Research — Image source: EIN Presswire

Recent News

AEG Celebrates the LGBTQIA + Community at the 2025 LA Pride Parade

What happens if AI can do everything better than humans?

Brookfield Infrastructure reportedly acquiring Hotwire for $7 billion

Nvidia GTC Paris is ’another bullish proof point’ long term - Morgan S...

CAMBRIDGE, MA, UNITED STATES, June 12, 2025 /EINPresswire.com/ -- ZoomRx, a leading life sciences strategic consultancy, today announced the launch of Sagan, a groundbreaking AI-powered platform designed to transform how pharma teams uncover insights from healthcare professionals and patients.

At its core, Sagan replaces outdated research methods with human-centered, AI-enhanced conversations. By uniting natural language interfaces, proprietary HCP/patient panels, and real-time analytics, Sagan enables pharmaceutical brands to get answers faster—and make better decisions sooner.

"For too long, life sciences research has forced a choice between the scale of data and the humanity of the story. Sagan changes all that. By centering the authentic perspectives of every HCP and patient, we can now deliver insights that have both quantitative rigor and profound qualitative depth—at a speed the industry has never seen before," explained Sriram Subramanian, ZoomRx's Co-CEO and Co-Founder.

Built around four foundational pillars—Authentic Voices, Natural Conversation, Limitless Scale, and Instant Answers—Sagan enables:

• On-demand AI-powered voice and text dialogues with real HCPs and patients
• Reimagined “Survey as a Conversation” offering, seamlessly blending qual and quant research types
• Voice-dictated patient chart audits via Patient Scribe
• On-demand simulations of HCP and patient personas
• Instant answers to any business question via Deep Search

ZoomRx will debut Sagan at the PMRC West Conference on June 12. People can experience Sagan for themselves now and see how ZoomRx is turning Carl Sagan’s words—“Somewhere, something incredible is waiting to be known”—into a reality for pharma teams everywhere.

Media Contact:
Conrad Walgren
[email protected]

Conrad Walgren
ZoomRx
+1 404-219-7631
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.